Company: HURA
Filing Date: 2025-08-12
Form Type: 8-K/A
Source: 0001193125-25-178993
Chunk: 2

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: 8-K/A
Chunk 2
---
), and cash flows for each of the years ended December 31, 2024 and 2023, and the related notes, are not required in the Original Report, as amended by this Amendment, because “substantially the same” financial statements were previously filed in TuHURA’s Registration Statement on Form S-4 (File No. 333-284787), initially filed on February 7, 2025, as amended, and declared effective by the Securities Exchange Commission on May 14, 2025. |

(b) Pro forma financial information. The following unaudited pro forma financial information of TuHURA is attached as Exhibit 99.2 to this Amendment and incorporated by reference herein:

| • |     | Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements. |

(d) Exhibits. The following documents are filed herewith as exhibits to this Amendment:

| Exhibit 
 No.     
 99.1    
 99.2    |     | Description                                                                                                                                                                           
 Unaudited Consolidated Financial Statements of Kineta, Inc. as of and for the three months ended March 31, 2025                                                                       
 Unaudited Pro Forma Condensed Combined Financial Information of TuHURA Biosciences, Inc. as of and for the three months ended March 31, 2025 and for the year ended December 31, 2024 |
|:--------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 104     |     | Cover page interactive data file (embedded within the inline XBRL document                                                                                                            |

#### SIGNATURESPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.TUHURA BIOSCIENCES, INC.Date: August 12, 2025By:/s/Dan DearbornName:Dan DearbornTitle:Chief Financial Officer